Factors regulating cell wall thickening and intracellular iodophilic polysaccharide storage in Streptococcus mutans. 1977

S J Mattingly, and L Daneo-Moore, and G D Shockman

The effects of a series of different antibiotics on the synthesis and accumulation of deoxyribonucleic acid (DNA), ribonucleic acid (RNA), protein, cell wall peptidoglycan (PG), and intracellular iodophilic polysaccharide (IPS) in Streptococcus mutans FA-1 were examined. d-Cycloserine, penicillin G, or vancomycin treatment resulted in rapid inhibitions of PG synthesis and a consequent decrease in the relative amount of lysine found in PG fractions. Decreases in culture turbidity, an indicator of gross cellular lysis, were not observed. Secondary inhibitions of the rates and extent of syntheses of DNA, RNA, and protein were observed. With all three inhibitors of PG synthesis, IPS synthesis continued for varying time intervals but, at most, resulted in only relatively small and transient increases in cellular IPS content. Chloramphenicol inhibited protein synthesis but permitted continued synthesis of RNA and PG. After 6 h, the cells contained 42% of their [(3)H] lysine in the PG fraction compared with 25% in exponential-phase cells, a good indication of thickened cell walls. In the presence of chloramphenicol, cellular IPS content increased about 2.5-fold during the first 45 min and then decreased to a level (13%) at 6 h very similar to that of exponential-phase cells (about 10%). Rifampin inhibition of RNA (and, consequently, also protein) synthesis resulted in accumulation of cellular PG and IPS. After 6 h, IPS accounted for 38% of the cellular dry weight, and the cells contained 43% of their lysine in PG. Thus, rifampin-inhibited cells appear to have both thickened walls and a high IPS content. The correlation between inhibition of RNA synthesis and IPS accumulation was confirmed by exposing cultures to rifampin for 60 min and then removing the drug, thus permitting the cells to regrow. Upon removal of rifampin and resumption of RNA synthesis, cellular IPS content rapidly decreased to the level expected for exponentialphase cells.

UI MeSH Term Description Entries
D010400 Penicillin G A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on GAMMA-AMINOBUTYRIC ACID mediated synaptic transmission. Benzylpenicillin,Benpen,Benzylpenicillin Potassium,Coliriocilina,Crystapen,Or-pen,Parcillin,Pekamin,Pengesod,Penibiot,Penicilina G Llorente,Penicillin G Jenapharm,Penicillin G Potassium,Penicillin G Sodium,Penicillin GrĂ¼nenthal,Penilevel,Peniroger,Pfizerpen,Sodiopen,Sodipen,Sodium Benzylpenicillin,Sodium Penicillin,Unicilina,Ursopen,Van-Pen-G
D010457 Peptidoglycan A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. Murein,Pseudomurein
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

S J Mattingly, and L Daneo-Moore, and G D Shockman
January 1963, Archives of oral biology,
S J Mattingly, and L Daneo-Moore, and G D Shockman
January 1982, Microbios,
S J Mattingly, and L Daneo-Moore, and G D Shockman
January 1978, Caries research,
S J Mattingly, and L Daneo-Moore, and G D Shockman
August 2021, Nature chemical biology,
S J Mattingly, and L Daneo-Moore, and G D Shockman
May 2024, bioRxiv : the preprint server for biology,
S J Mattingly, and L Daneo-Moore, and G D Shockman
January 1971, Caries research,
S J Mattingly, and L Daneo-Moore, and G D Shockman
May 1986, Infection and immunity,
S J Mattingly, and L Daneo-Moore, and G D Shockman
August 1974, Infection and immunity,
S J Mattingly, and L Daneo-Moore, and G D Shockman
December 2009, Journal of bacteriology,
Copied contents to your clipboard!